REAGENS Kft of Budapest at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine


Wysocki utca 1, 1155 Budapest
Telephone +36 1 3498775
Fax +36 1 3508354

Hall map

MEDICA 2018 hall map (Hall 18): stand D01

Fairground map

MEDICA 2018 fairground map: Hall 18

Our range of products

Product categories

  • 03  Diagnostic Tests
  • 03.03  Haematology / histology / cytology testing
  • 03.03.03  Immunohaematology testing, blood grouping

Immunohaematology testing, blood grouping

Our products

Product category: Immunohaematology testing, blood grouping

ReaCell Screening Cells

The ReaCell Screening Cells are in vitro diagnostic medical devices (IVDMD) of human origin to detect patient's and donor's irregular (IgM and IgG) antibodies, which may cause haemolitic anemia, transfusion reactions and complications, haemolitic disease of the newborn.

The non-enzymatised ReaCell I, II, III Screening Cells detect IgM (mainly M, N) and IgG (Rh-, Kell-, Duffy-, Kidd-, etc.) system's irregular antibodies with direct agglutination, and indirect antiglobulin (indirect Coombs) technique.

The ReaCell IP, IIP, IIIP enzymatised (papainised) Screening Cells are reacting in enzymatised medium IgM and IgG, for detecting mainly Rh system's irregular antibodies with direct agglutination technique. The Kell system's antibodies may react this way as well. The  Screening Cells are able to detect several cold IgM antibodies (anti-I, Anti-H, anti-P1, anti-Lea, anti-Leb). The enzym treatment destroys the Fya, Fyb, M, N and partially S antigens, this kind of antigens can't be detected with enzymatised Screening Cells.

The ReaCell Screening Cells contains 3-3 „0” group, with known antibody property suspension. We are providing for each batch an antigen chart with the product.

More Less

Product category: Immunohaematology testing, blood grouping

ReaCell AB0 Test Cells

The ReaCell AB0 Test Cells are in vitro diagnostic medical devices (IVDMD) of human origin. They are designed for analysis of human biological samples. These test cells are being used for determination of AB0 blood group antibodies (anti-A, anti-B) in human serum or plasma.

The detection of anti-A and/or anti-B in the serum/plasma is a complementary part of blood grouping; by the presence or absence of anti-A and/or anti-B antibodies supports the evaluation of the reactions between the red blood cells and test sera.

On natural conditions the serum/plasma of persons with “A” blood group contains anti-B antibodies, the serum/plasma of persons with “B” blood group contains anti-A antibodies, the serum/plasma of persons with “0” blood group contains either anti-A or anti-B, and the others with “AB” blood group contains neither anti-A, nor anti-B.

If the serum/plasma to be tested contains anti-A, it will agglutinate the A1 and A2 test cells.

The ReaCell AB0 Test Cells containing variation of vials of blood grouping cells
A1,A2, B, 0, with different reference numbers, see Packaging. The A1 group test cells are RhD negative.

The red blood cells are prepared in the method wanted concentration ready-to-use, preservative suspension, filled in 5 ml and 10 ml vials fitted with a calibrated dropper.

More Less

About us

Company details

REAGENS Ltd. was established by three owners in 1990, with over 25 years experience in manufacturing and distributing of medical devices and reagents.

REAGENS played a pioneer role in introducing environment friendly new reagents to the Hungarian market.
As a result of continuous and intensive technology development only REAGENS preserves red blood cells in Hungary for blood serology purposes.

By manufacturing and distributing of ReaCell branded AB0, Screening and Panel cells, together with the internal and external immunohematology control products, REAGENS Ltd. achieved a significant market share. 

In order to fulfill our customers request at a high quality level – we are distributing many more products of foreign companies.

More Less